SMTL ID : 7wz9.1

HSA-In agent complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.83 Å

Oligo State

monomer

Ligands

6 x PLM: PALMITIC ACID(Non-covalent)

PLM.1: 7 residues within 4Å: Chain A: R.115, L.133, Y.136, L.137, A.156, Y.159, F.163 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.136, A:A.156, A:Y.159, A:Y.159, A:Y.159, A:F.163 Salt bridges: A:R.115, A:R.184 PLM.2: 15 residues within 4Å: Chain A: R.8, L.12, L.20, V.44, L.64, L.67, F.68, Y.148, L.248, L.249, A.252, R.255, L.281, L.282, S.285 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.20, A:V.44, A:L.64, A:L.67, A:F.68, A:L.248, A:L.249, A:A.252 Hydrogen bonds: A:Y.148, A:S.285 Salt bridges: A:R.255 PLM.3: 14 residues within 4Å: Chain A: S.340, V.342, R.346, P.382, L.385, I.386, N.389, C.390, G.432, M.444, E.448, L.451, R.483 Ligands: PLM.4 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:P.382, A:L.385, A:I.386, A:E.448 Hydrogen bonds: A:S.340, A:L.343 Salt bridges: A:R.346, A:R.483 PLM.4: 14 residues within 4Å: Chain A: L.385, Y.409, K.412, V.413, V.416, T.420, L.428, L.455, L.458, L.461, H.462, F.486, S.487 Ligands: PLM.3 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.409, A:V.413, A:V.416, A:L.428, A:L.455, A:L.458, A:L.458, A:L.461, A:H.462, A:F.486, A:F.486 Hydrogen bonds: A:Y.409, A:S.487 Salt bridges: A:K.412 PLM.5: 12 residues within 4Å: Chain A: Y.399, F.500, F.505, K.523, A.526, L.530, H.533, V.545, M.546, F.549, A.550, S.577 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:F.500, A:F.505, A:A.526, A:L.530, A:L.530, A:V.545, A:M.546, A:F.549, A:F.549 Salt bridges: A:K.523 PLM.6: 7 residues within 4Å: Chain A: R.207, A.208, S.230, D.322, A.348, K.349, E.352 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:A.208, A:A.348

1 x 7Q8: 16-chloranyl-~{N},~{N}-dimethyl-15-thia-1$l^{4},12$l^{4},13-triaza-16$l^{4}-indatetracyclo[8.6.0.0^{2,7}.0^{12,16}]hexadeca-1,3,5,7,9,11,13-heptaen-14-amine(Non-covalent)

7Q8.7: 9 residues within 4Å: Chain A: L.113, I.140, R.143, H.144, F.147, L.152, F.155, Y.159, G.187 5 PLIP interactions: 5 interactions with chain A, Hydrophobic interactions: A:L.152 pi-Stacking: A:H.144, A:F.147, A:F.155 Metal complexes: A:H.144

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhang, Z. et al., Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy. J.Med.Chem. (2022)

Release Date

2023-02-22

Peptides

Serum albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serum albumin

Related Entries With Identical Sequence